Psychological and Psychiatric Assessment in Patients Eligible for Epilepsy Surgery
NCT ID: NCT06792383
Last Updated: 2026-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
180 participants
INTERVENTIONAL
2020-12-02
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Neurocognitive Plasticity in Patients With Focal and Drug-resistant Epilepsy
NCT03543267
Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies
NCT03244345
Cortical Excitability Assessment Using Paired Pulses
NCT02245061
Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia
NCT03321240
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
NCT06782074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This longitudinal, non-pharmacological interventional clinical study will be conducted at the Clinical and Experimental Epileptology Unit of the Institute. The enrollment will last for 24 months, during which approximately 30 patients with drug-resistant focal epilepsy eligible for epilepsy surgery will be enrolled, from both genders, aged at least 18 years.
Two groups of patients eligible for epilepsy surgery will be enrolled:
* Study group: patients with drug-resistant focal epilepsy eligible for epilepsy surgery who will undergo the procedure immediately.
* Control group: patients with drug-resistant focal epilepsy eligible for epilepsy surgery who, due to the need for further investigations and evaluations, will undergo the surgery at least 1 year after the baseline.
For the study group, data will be collected at three time points:
* At the time of pre-surgical hospitalization (baseline)
* 6 months after epilepsy surgery, during the first post-surgical follow-up visit (FU1)
* 12 months after epilepsy surgery, during the second post-surgical follow-up visit (FU2)
For the control group, data will be collected at three time points as well:
* At the time of surgical indication (baseline)
* 6 months after baseline and before epilepsy surgery (FU1)
* 12 months after baseline and before epilepsy surgery (FU2) At all three data collection time points, clinical psychological interviews and the administration of questionnaires evaluating the study variables will be conducted for both groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
* Quality of Life in Epilepsy (QOLIE-31)26
* • Dissociative Experience Scale (DES)27
* • Symptom Checklist-90 (SCL-90)28
* • Irritability Questionnaire (I-EPI)29
* • Beck Depression Inventory II (BDI-II)30
* • State-Trait Anxiety Inventory Y-1 e Y-2 (STAI)31
* • Epilepsy Stigma Scale modificata32 These assessment tools are validated and used universally, and will allow the collection of information on the psychological and psychiatric functioning of the patients.
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with drug-resistant focal epilepsy
patients with drug-resistant focal epilepsy eligible for epilepsy surgery who will undergo the procedure immediately.
quality of life
The following assessment tools will be proposed to patients:
* Quality of Life in Epilepsy (QOLIE-31)26
* Dissociative Experience Scale (DES)27
* Symptom Checklist-90 (SCL-90)28
* Irritability Questionnaire (I-EPI)29
* Beck Depression Inventory II (BDI-II)30
* State-Trait Anxiety Inventory Y-1 e Y-2 (STAI)31
* Epilepsy Stigma Scale modificata32 These assessment tools are validated and used universally, and will allow the collection of information on the psychological and psychiatric functioning of the patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
quality of life
The following assessment tools will be proposed to patients:
* Quality of Life in Epilepsy (QOLIE-31)26
* Dissociative Experience Scale (DES)27
* Symptom Checklist-90 (SCL-90)28
* Irritability Questionnaire (I-EPI)29
* Beck Depression Inventory II (BDI-II)30
* State-Trait Anxiety Inventory Y-1 e Y-2 (STAI)31
* Epilepsy Stigma Scale modificata32 These assessment tools are validated and used universally, and will allow the collection of information on the psychological and psychiatric functioning of the patients.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with drug-resistant focal epilepsy followed at the Institute for at least 6 months;
* Patients with drug-resistant focal epilepsy eligible for epilepsy surgery;
* Patients capable of providing informed consent to participate in the study and for the processing of personal data.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco de Curtis, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical and Experimental Epileptology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via G. Celoria 11, 20133 Milano, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation IRCCS Carlo Besta Neurological Institute
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Sawant N, Ravat S, Muzumdar D, Shah U. Is psychiatric assessment essential for better epilepsy surgery outcomes? Int J Surg. 2016 Dec;36(Pt B):460-465. doi: 10.1016/j.ijsu.2015.06.025. Epub 2015 Jun 12.
Locharernkul C, Kanchanatawan B, Bunyaratavej K, Srikijvilaikul T, Deesudchit T, Tepmongkol S, Lertlum S, Tuchinda L, Shoungshotti C, Ounpak P. Quality of life after successful epilepsy surgery: evaluation by occupational achievement and income acquisition. J Med Assoc Thai. 2005 Sep;88 Suppl 4:S207-13.
Devinsky O, Penry JK. Quality of life in epilepsy: the clinician's view. Epilepsia. 1993;34 Suppl 4:S4-7. doi: 10.1111/j.1528-1157.1993.tb05916.x.
Deleo F, Quintas R, Pastori C, Pappalardo I, Didato G, Di Giacomo R, de Curtis M, Villani F. Quality of life, psychiatric symptoms, and stigma perception in three groups of persons with epilepsy. Epilepsy Behav. 2020 Sep;110:107170. doi: 10.1016/j.yebeh.2020.107170. Epub 2020 Jun 5.
Shneker BF, Fountain NB. Epilepsy. Dis Mon. 2003 Jul;49(7):426-78. doi: 10.1016/s0011-5029(03)00065-8.
Langfitt JT, Westerveld M, Hamberger MJ, Walczak TS, Cicchetti DV, Berg AT, Vickrey BG, Barr WB, Sperling MR, Masur D, Spencer SS. Worsening of quality of life after epilepsy surgery: effect of seizures and memory decline. Neurology. 2007 Jun 5;68(23):1988-94. doi: 10.1212/01.wnl.0000264000.11511.30.
Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Haut S, Langfitt JT, Walczak TS, Devinsky O; Multicenter Study of Epilepsy Surgery. Health-related quality of life over time since resective epilepsy surgery. Ann Neurol. 2007 Oct;62(4):327-34. doi: 10.1002/ana.21131.
Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007 Dec;48(12):2336-44. doi: 10.1111/j.1528-1167.2007.01222.x. Epub 2007 Jul 28.
Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, Gatti G, La Neve A, Muscas G, Specchio LM, Striano S, Perucca E; SOPHIE Study Group. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia. 2011 Dec;52(12):2181-91. doi: 10.1111/j.1528-1167.2011.03325.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PsychoSurgery
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.